Citi Starts MacroGenics (MGNX) at Neutral
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.58 --0%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Citi initiated coverage on MacroGenics (NASDAQ: MGNX) with a Neutral rating and a price target of $31.00.
For an analyst ratings summary and ratings history on MacroGenics click here. For more ratings news on MacroGenics click here.
Shares of MacroGenics closed at $27.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
- Cantor Fitzgerald Starts Quince Therapeutics Inc. (QNCX) at Overweight
- H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
